A Drosophila melanogaster model of classic galactosemia

DMM Disease Models and Mechanisms

Volumn 3, Issue 9-10, 2010, Pages 618-627

  Kushner, Rebekah F ^a   Ryan, Emily L ^a   Sefton, Jennifer M I ^a   Sanders, Rebecca D ^a   Lucioni, Patricia Jumbo ^b   Moberg, Kenneth H ^b   Fridovich Keil, Judith L ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; GALACTOSEMIA; INTESTINE LYMPHATIC TISSUE; LARVA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ALLELES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; GALACTOSE; GALACTOSEMIAS; GALACTOSEPHOSPHATES; GRAVITROPISM; HOMOZYGOTE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; TIME FACTORS; TRANSGENES; UTP-HEXOSE-1-PHOSPHATE URIDYLYLTRANSFERASE;

ANIMALIA; DROSOPHILA MELANOGASTER;

EID: 77956536754     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.005041     Document Type: Article

References (36)

1. Akai, S. (1979). Genetic variation in walking ability of Drosophila melanogaster. Jpn J. Genet. 54, 317-324. (Pubitemid 10208285)
2. Benzer, S. (1967). Behavioral mutants of Drosophila isolated by countercurrent distribution. Proc. Natl. Acad. Sci. USA 58, 1112-1119.
3. Bharucha, K. (2009). The epicurean fly: using Drosophila melanogaster to study metabolism. Pediatr. Res. 65, 132-137.
4. Bier, E. (2005). Drosophila, the golden bug, emerges as a tool for human genetics. Nat. Rev. Genet. 6, 9-23.
5. Bosch, A., Bakker, H., Wenniger-Prick, L., Wanders, R. and Wijburg, F. (2004). High tolerance for oral galactose in classical galactosaemia: dietary implications. Arch. Dis. Child. 89, 1034-1036.
6. Brand, A. and Perrimon, N. (1993). Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415. (Pubitemid 23214028)
7. Chien, S., Reiter, L., Bier, E. and Gribskov, M. (2002). Homophila: human disease gene cognates in Drosophila. Nucleic Acids Res. 30, 149-151. (Pubitemid 34679527)
8. Christacos, N. C. and Fridovich-Keil, J. L. (2002). Impact of patient mutations on heterodimer formation and function in human galactose-1-P uridylyltransferase. Mol. Genet. Metab. 76, 319-326.
9. Elsevier, J. P. and Fridovich-Keil, J. L. (1996). The Q188R mutation in human galactose-1-phosphate uridylyltransferase acts as a partial dominant negative. J. Biol. Chem. 271, 32002-32007.
10. Elsevier, J. P., Wells, L., Quimby, B. B. and Fridovich-Keil, J. L. (1996). Heterodimer formation and activity in the human enzyme galactose-1-phosphate uridylyltransferase. Proc. Natl. Acad. Sci. USA 93, 7166-7171.
11. Fridovich-Keil, J. L. and Jinks-Robertson, S. (1993). A yeast expression system for human galactose-1-phosphate uridylyltransferase. Proc. Natl. Acad. Sci. USA 90, 398-402. (Pubitemid 23028869)
12. Fridovich-Keil, J. and Walter, J. (2008). Galactosemia. In The Online Metabolic and Molecular Bases of Inherited Disease - OMMBID (ed. D. Valle, A. Beaudet, B. Vogelstein, K. Kinzler, S. Antonarakis and A. Ballabio), Chapter 72. New York: McGraw-Hill. www.ommbid.com.
13. Fridovich-Keil, J. L., Langley, S. D., Mazur, L. A., Lennon, J. C., Dembure, P. P. and Elsas, L. J. (1995a). Identification and functional analysis of three distinct mutations in the human galactose-1-phosphate uridyltransferase gene associated with galactosemia in a single family. Am. J. Hum. Gen. 56, 640-646.
14. Fridovich-Keil, J. L., Quimby, B. B., Wells, L., Mazur, L. A. and Elsevier, J. P. (1995b). Characterization of the N314D allele of human galactose-1-phosphate uridylyltransferase using a yeast expression system. Biochem. Mol. Med. 56, 121-130. (Pubitemid 26029434)
15. Holden, H. M., Rayment, I. and Thoden, J. B. (2003). Structure and function of enzymes of the Leloir pathway for galactose metabolism. J. Biol. Chem. 278, 43885-43888.
16. Honjo, K. and Furukubo-Tokunaga, K. (2005). Induction of cAMP response element-binding protein-dependent medium-term memory by appetitive gustatory reinforcement in Drosophila larvae. J. Neurosci. 25, 7905-7913. (Pubitemid 41254393)
17. Keyes, L. and Spradling, A. (1997). The Drosophila gene fs(2)cup interacts with otu to define a cytoplasmic pathway required for the structure and function of germ-line chromosomes. Development 124, 1419-1431. (Pubitemid 27190114)
18. Lai, K. and Elsas, L. (2000). Overexpression of human UDP-glucose pyrophosphorylase rescues galactose-1-phosphate uridyltransferase-deficient yeast. Biochem. Biophys. Res. Commun. 271, 392-400. (Pubitemid 30444737)
19. Lai, K., Langley, S. D., Singh, R. H., Dembure, P. P., Hjelm, L. N. and Elsas, L. J. (1996). A prevalent mutation for galactosemia among black Americans. J. Pediatr. 128, 89-95. (Pubitemid 26028962)
20. Lai, K., Langley, S., Khwaja, F., Schmitt, E. and Elsas, L. (2003). GALT deficiency causes UDP-hexose deficit in human galactosemic cells. Glycobiology 13, 285-294. (Pubitemid 36592315)
21. Lasko, P. (2002). Diabetic flies? Using Drosophila melanogaster to understand the causes of monogenic and genetically complex diseases. Clin. Genet. 62, 358-367.
22. Leslie, N. D. (2003). Insights into the pathogenesis of galactosemia. Annu. Rev. Nutr. 23, 59-80.
23. Leslie, N. and Bai, S. (2001). Functional analysis of the mouse galactose-1-phosphate uridyl transferase (GALT) promoter. Mol. Genet. Metab. 72, 31-38. (Pubitemid 34169348)
24. Leslie, N. D., Yager, K. L., McNamara, P. D. and Segal, S. (1996). A mouse model of galactose-1-phosphate uridyl transferase deficiency. Biochem. Mol. Med. 59, 7-12.
25. Leslie, N., Yager, C., Reynolds, R. and Segal, S. (2005). UDP-galactose pyrophosphorylase in mice with galactose-1-phosphate uridyltransferase deficiency. Mol. Genet. Metab. 85, 21-27. (Pubitemid 40603021)
26. Ning, C., Reynolds, R., Chen, J., Yager, C., Berry, G. T., McNamara, P. D., Leslie, N. and Segal, S. (2000). Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency. Pediatr. Res. 48, 211-217. (Pubitemid 30497339)
27. Ning, C., Reynolds, R., Chen, J., Yager, C., Berry, G., Leslie, N. and Segal, S. (2001). Galactose metabolism in mice with galactose-1-phosphate uridyltransferase deficiency: sucklings and 7-week-old animals fed a high-galactose diet. Mol. Genet. Metab. 72, 306-315. (Pubitemid 34171425)
28. Openo, K., Schulz, J., Vargas, C., Orton, C., Epstein, M., Schnur, R., Scaglia, F., Berry, G., Gottesman, G., Ficicioglu, C. et al. (2006). Epimerase-deficiency galactosemia is not a binary condition. Am. J. Hum. Genet. 78, 89-102.
29. Panis, B., Bakker, J. A., Sels, J. P., Spaapen, L. J., van Loon, L. J. and Rubio-Gozalbo, M. E. (2006). Untreated classical galactosemia patient with mild phenotype. Mol. Genet. Metab. 89, 277-279.
30. Piccioni, F., Zappavigna, V. and Verrotti, A. (2005). A cup full of functions. RNA Biol. 2, 125-128.
31. Riehman, K., Crews, C. and Fridovich-Keil, J. L. (2001). Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase. J. Biol. Chem. 276, 10634-10640.
32. Ross, K. L., Davis, C. N. and Fridovich-Keil, J. L. (2004). Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast. Mol. Gen. Metab. 83, 103-116.
33. Ryder, E. and Russell, S. (2003). Transposable elements as tools for genomics and genetics in Drosophila. Brief. Funct. Genomic. Proteomic. 2, 57-71.
34. Sanders, R., Sefton, J., Moberg, K. and Fridovich-Keil, J. L. (2010). UDP-galactose 4' epimerase (GALE) is essential for development of Drosophila melanogaster. Dis. Model. Mech. 3, (in press) [doi:10.1242/dmm.005058].
35. Tyfield, L. and Walter, J. (2002). Galactosemia. In The Metabolic and Molecular Bases of Inherited Disease (ed. C. Scriver, A. Beaudet, W. Sly, D. Valle, B. Childs, K. Kinzler and B. Vogelstein). New York: McGraw-Hill.
36. Zhang, H., Liu, J., Li, C., Momen, B., Kohanski, R. and Pick, L. (2009). Deletion of Drosophila insulin-like peptides causes growth defects and metabolic abnormalities. Proc. Natl. Acad. Sci. USA 106, 19617-19622.